West Bengal is intensifying its focus on pharmaceutical manufacturing as part of a broader industrial development strategy aimed at attracting investment and boosting economic growth. According to recent reports, the state government is exploring opportunities to strengthen the pharma ecosystem alongside sectors such as chemicals, food processing, and textiles.
Industry observers believe Bengal’s strategic connectivity, skilled workforce, academic infrastructure, and growing industrial base could create favorable conditions for pharmaceutical expansion in eastern India. Increased emphasis on manufacturing and healthcare infrastructure may also open new avenues for employment, innovation, and regional economic development.
The development reflects India’s larger push toward strengthening domestic pharmaceutical production and reducing dependence on external supply chains. Experts from the healthcare and industrial sectors have welcomed the discussion, stressing the need for policy support, research collaboration, and sustainable investment to build a competitive pharmaceutical landscape in the state.
The move has generated growing interest across the pharma and healthcare community.
By Sharon Bose & Arundhuti Chatterjee
